- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Reneo Pharmaceuticals (NASDAQ:RPHM), Quotes and News Summary
Reneo Pharmaceuticals (NASDAQ: RPHM)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-19 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.540 | -0.530 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Reneo Pharmaceuticals Questions & Answers
You can purchase shares of Reneo Pharmaceuticals (NASDAQ: RPHM) through any online brokerage.
Other companies in Reneo Pharmaceuticals’s space includes: Virios Therapeutics (NASDAQ:VIRI), Lumos Pharma (NASDAQ:LUMO), Aligos Therapeutics (NASDAQ:ALGS), Infinity Pharmaceuticals (NASDAQ:INFI) and Gemini Therapeutics (NASDAQ:GMTX).
The latest price target for Reneo Pharmaceuticals (NASDAQ: RPHM) was reported by Piper Sandler on Wednesday, May 18, 2022. The analyst firm set a price target for 18.00 expecting RPHM to rise to within 12 months (a possible 576.69% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Reneo Pharmaceuticals (NASDAQ: RPHM) is $2.66 last updated Today at August 8, 2022, 8:00 PM UTC.
There are no upcoming dividends for Reneo Pharmaceuticals.
Reneo Pharmaceuticals’s Q2 earnings are confirmed for Friday, August 19, 2022.
There is no upcoming split for Reneo Pharmaceuticals.
Reneo Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.